Results 241 to 250 of about 43,358 (290)

Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background Acne vulgaris is a common inflammatory skin disorder with significant psychosocial impact. While isotretinoin remains the gold standard for moderate‐to‐severe cases, its adverse effects and teratogenicity underscore the need for alternative systemic therapies.
Nello Tommasino   +3 more
wiley   +1 more source

Machine Learning Model for an App‐Based Tool to Assist With the Diagnosis of Canine Atopic Dermatitis

open access: yesVeterinary Dermatology, Volume 37, Issue 2, Page 236-246, April 2026.
Canine atopic dermatitis (cAD) is a chronic condition requiring life‐long management. Accurate diagnosis can be challenging, with no reliable diagnostic test. This study aimed to generate a simple diagnostic model for cAD. This model is a relevant prototype for an app‐based tool to support general practitioners in the diagnosis of cAD alongside ...
Xavier Langon   +2 more
wiley   +1 more source

Dermatitis neglecta after using Isotretinoin: case series. [PDF]

open access: yesOxf Med Case Reports
Dukhan A   +4 more
europepmc   +1 more source

[Myelopathy secondary to thoracic actinomycetoma]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Damián-Zapién A   +4 more
europepmc   +1 more source

Refractory Lichen Amyloidosis Coexisting With Atopic Dermatitis Responsive to Sequential Janus Kinase Inhibitor Therapy: Upadacitinib Followed by Abrocitinib

open access: yes
The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 4, April 2026.
Yu‐Ting Tsai   +2 more
wiley   +1 more source

An Unusual Case of Tinzaparin-Induced Haemorrhagic Bullous Dermatosis: Diagnostic and Therapeutic Challenges. [PDF]

open access: yesEur J Case Rep Intern Med
Abdelhamid K   +4 more
europepmc   +1 more source

Idiopathic Facial Aseptic Granuloma: A Case Report. [PDF]

open access: yesCureus
Patrocínio J   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy